26: 249-255. Background. Although ethnic and racial differences in uterine corpus cancer incidence and mortality have been reported worldwide, few published data have addressed the epidemiology of uterine cancer among US American Indians and Hispanics. Methods. We reviewed uterine corpus cancer incidence and survival data from New Mexico's population-based cancer registry collected from 1969 to 1992, and examined State vital records data for uterine cancer deaths collected from 1958 to 1992, focusing on ethnic differences in occurrence and outcomes of uterine malignancies. Results. Non-Hispanic white women had age-adjusted incidence rates that were substantially higher (20.8 per 100 000) than rates for Hispanics (10.3) and American Indians (6.0) over the 24-year period. Uterine cancer mortality rates were also higher for non-Hispanic whites and Hispanics than for American Indian women, although mortality rates were substantially lower than incidence rates. Five-year survival for uterine cancer was comparable among all groups for all stages combined (87.3% for non-Hispanic whites, 81.4% for Hispanics, and 84.6% for American Indians). Conclusions. Our population-based data show ethnic differences in uterine corpus cancer incidence rates for nonHispanic white women that were double those for Hispanics, and triple those for American Indian women. Ethnic differences in survival were comparable. Aetiologic studies are warranted to investigate the dramatic ethnic differences in occurrence of uterine cancer.
METHODS

Incidence Data
The New Mexico Tumor Registry, a member of the Surveillance, Epidemiology and End Results (SEER) program of the National Cancer Institute, has recorded population-based cancer incidence in New Mexico since 1969. Uterine corpus cancer cases were identified through active surveillance of hospital records, outpatient clinic records, pathology and autopsy reports, and radiation therapy records. The Registry also reviews state death certificates that mention uterine cancer as cause of death.
The International Classification of Diseases for Oncology (ICD-O) 5 coding for uterine cancer differentiates uterine corpus from uterine cervix cancer. Uterine corpus cancer cases were coded as 182.0-182.2 in the ICD-O. Stage of disease was defined using the SEER definitions for extent of disease. The summary stages of local, regional, and distant stages were used. Local cancers were defined as those confined to the uterine corpus or endometrium. Regional cancers involved local structures in the pelvis beyond the uterus, including the endocervix, parametrium, pelvic wall, ovary, fallopian tubes, rectal or bladder wall, as well as regional lymph node involvement. Distant cancers were those that extended to the vagina, vulva, rectum or bladder mucosa, ureter, sigmoid colon, small intestine, serosa of abdominal organs, or other distant involvement. Cancers were assigned to an unknown stage if insufficient information was available to assign a stage or if staging occurred more than 2 months after histological diagnosis. From 1969 to 1992, 2.2% of uterine cancers were diagnosed at an unknown stage. A total of 2549 incident uterine cancer cases were included in this analysis.
In addition to uterine corpus cancer, the SEER registries includes the category of 'uterus, NOS' (code 179.9 in ICD-O). This classification includes cancer of the uterus that is not specifically identified on data abstraction as corpus or cervical cancer. We reviewed all of the New Mexico SEER registry cases of 'uterus, NOS' and reassigned cases to uterine corpus or uterine cervix cancer if additional information was available. Over the span of the study, 1969-1992, only 1.4% (37 of 2586) of cases were in the category 'uterus, NOS'.
We used histopathological classifications for uterine cancer in our analysis that were consistent with the classification scheme as recently reported in an analysis of national SEER data. 6 The major categories of histopathological types that we included were adenocarcinomas, sarcomas, and 'other' histopathological types (including endometrial stromal sarcomas, carcinosarcomas, and mullerian mixed tumours). There were too few cases by ethnic group to allow further stratification by histopathological types. We included only invasive cases of uterine corpus cancer in the analysis.
Methods used to assign race and ethnicity and the validation of these methods have been reported previously. 7, 8 As noted in earlier publications, 7, 8 methods for assignment of race and ethnicity have been constant throughout the period of data collection. Self-reported ethnic status as Hispanic, American Indian, and nonHispanic white was highly correlated with assignation of ethnicity through the SEER registries. 7, 8 The New Mexico Hispanic population is a heterogeneous group comprised predominantly of descendants from settlers from New Spain as well as more recent immigrants from Mexico. Because of the small number of Blacks, Asians, and members of other ethnic groups in New Mexico, we restricted this analysis to the three ethnic groups as noted above.
Mortality Data
Uterine cancer deaths were coded as 172-173 in the Seventh International Classification of Diseases (ICD), 9 as 182.0 in ICD-8, 10 and as 182.0, 182.1 and 182.8 in ICD-9-CM (ICD-9-Clinical Modification).
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Coded death certificate data were obtained from the New Mexico Bureau of Vital Records and Health Statistics for the period from 1958 through 1992. As described in earlier reports, 7, 8, 12 the Bureau's coding procedures have been consistent throughout the study period. Furthermore, the comparability ratios for coding of uterine cancer deaths have been close to 1.0 among all three versions of the ICD manuals in use over the 35-year span of our mortality data. 13, 14 The 'uterus, NOS' category (coded as 174.9 in ICD-7, 182.9 in ICD-8, and 179 in ICD-9-CM) comprised a substantial proportion of all cancer deaths and was reported separately.
Data Analysis
Population estimates for New Mexico used to calculate incidence and mortality rates in this study were derived from the censuses of 1960, 15 1970, 16 1980, 17 and 1990 . 18 Estimates of the American Indian population were not as accurate in the earlier years (1960s) of the study because of technical difficulties with the 1960 census data. 19 Estimates of the American Indian population in 1960 and of the Hispanic population in 1960 and 1970 were adjusted for systematic errors in processing and for the different techniques used to identify individuals of Hispanic ethnicity. 8 For time periods not centered on a census year, the population was estimated for the period midpoints by extrapolation or interpolation. Average annual age-specific and age-standardized incidence rates for all local, regional, and distant stages of uterine cancer were calculated for the periods 1969-1972, 1973-1977, 1978-1982, 1983-1987, and 1988-1992 . We analysed the data in these 5-year intervals to facilitate comparisons with published data from other reports. 6 Age-adjusted and age-specific mortality rates were calculated for the same period as the incidence rates and also for the earlier periods, 1958-1962 and 1963-1967 . Age-adjusted rates were calculated by the direct method using the 1970 US population as a standard. Relative 5-year survival was calculated using the methods described by Ederer et al. 20 The probabilities of surviving a certain number of years after cancer diagnosis are obtained from the relevant life tables for individuals in the cohort and summed to get the expected number of survivors after that number of years; the expected survival is obtained by dividing by the initial size of the cohort. Analyses were performed using standard SAS procedures 21 and PcDash, a locallydeveloped software package for analysis of SEER data that also includes analytical programs for calculating relative survival. Table 1 shows the age-adjusted incidence rates for all stages of uterine cancer combined excluding the cancer cases of 'uterus, NOS'. Non-Hispanic white women had a higher age-adjusted incidence rate compared with Hispanic and American Indian women over each of the 5-year time periods we examined. For the entire 24 years combined, the incidence rate for non-Hispanic whites was twofold higher than for Hispanics, and 3.5-fold higher than the rate for American Indian women (Table 1) . Rates for both non-Hispanic whites and for Hispanics remained relatively stable by 5-year time period. Age-adjusted incidence rates for American Indians showed consistent increases by 5-year time period, although the rate calculations were based on small numbers of cases. Almost half of all cases of uterine cancer diagnosed among American Indian women during the last 24 years occurred in the most recent 5-year time period, 1988-1992.
RESULTS
A large proportion of all uterine cancer cases were diagnosed in local stage-81% for non-Hispanic whites, 78% for Hispanics and 73% for American Indians. Incidence rates for each stage of disease remained relatively stable from the initial to the most recent time period for each of the three ethnic groups (Table 1) .
Age-adjusted incidence rates for cancer of the uterus, NOS decreased over the 24-year study period although rates were based on small numbers of cases (data not shown). For the 1969-1992 study period, these rates varied by ethnicity with rates for non-Hispanic whites (0.5 per 100 000) and Hispanics (0.6 per 100 000) higher than rates for American Indians (0.1 per 100 000). Patterns of age-specific incidence rates for uterine cancer also varied by ethnic group (Figure 1 ). Over the entire time period (1969-1992), age-specific rates by 5-year age group were higher among older versus younger groups of non-Hispanic whites, with the highest rates for women aged 70-74 years. This pattern contrasts with that of American Indian women, who showed relatively low age-specific incidence rates for women aged 70-74 years and older.
The distribution of histopathological types was comparable among the three ethnic groups. For each ethnic group, adenocarcinomas comprised the largest proportion of uterine cancers observed from 1969 to 1992-89.4% of all uterine cancers for all ethnic groups combined. Sarcomas comprised 2.7% of all uterine cancers in our series, while other histological types comprised 3.1%. Proportional distribution of these histological types did not change over time.
Over the span of the study, 5-year survival for all stages combined was 87.3% for non-Hispanic whites, 81.4% for Hispanics, and 84.6% for American Indians. Survival for local stage disease was comparable among each ethnic group (Ͼ90% for each group). We found lower 5-year survival among Hispanic compared to non-Hispanic white women for regional (60.8% versus 70.5 %) and distant (15.2% versus 24.8%) disease. Too few cases were recorded for American Indians to allow meaningful comparisons. Relative survival for uterine cancer did not differ for two time periods (1969) (1970) (1971) (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) Age-adjusted mortality rates for uterine corpus cancer and 'uterus, NOS' were substantially lower than uterine cancer incidence rates (Table 2) . Mortality rates varied by ethnic group, with the highest rates observed for non-Hispanic whites and Hispanics from 1958-1992. The mortality rates for 'uterus, NOS' cancers decreased substantially for non-Hispanic whites and for Hispanics over the span of the data. Age-adjusted mortality rates increased for non-Hispanic whites and Hispanics during the 35-year study period, with peaks during the mid1970s for non-Hispanic whites and the mid1980s for Hispanics. The small number of cases for American Indians resulted in great variability in rates by 5-year time period.
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a Rates per 100 000, adjusted to 1970 US population.
DISCUSSION
Population-based uterine cancer data in New Mexico showed that non-Hispanic white women had substantially higher age-adjusted incidence rates than American Indian and Hispanic women. Rates for nonHispanic whites resembled trend data reported in other studies. 1, 4 Incidence rates for Hispanics were relatively stable over the 24-year span of the data, in contrast to rates for American Indians which increased (especially from the 1983-1987 to 1988-1992 time period). During a 35-year period, uterine cancer mortality increased for non-Hispanic whites and Hispanics, although mortality rates were low compared to incidence rates. The distribution of histopathological types of uterine tumours was similar for all three of the State's largest ethnic groups Few published reports on uterine cancer among US American Indians and Hispanics are available for comparison with our population-based data. Incidence and mortality in American Indians varies by geographical location. [22] [23] [24] Reports on Hispanics in Denver, 25 California, 26 and New York 27 indicated lower uterine cancer incidence compared with whites. Among Florida's Hispanics, however, incidence rates were comparable to those for non-Hispanic whites. 28 These studies of Hispanics involved different subgroups-mainly MexicanAmericans in the Denver and California studies, Puerto Ricans in the New York and Cubans in the Florida studies. Among most Hispanic populations, uterine cancer occurrence appears to be lower compared to non-Hispanic whites.
The explanations for findings in New Mexico (Table 1) are not entirely clear. The strongest risk factors for uterine cancer include prolonged exposure to endogenous or exogenous oestrogens [29] [30] [31] and obesity. 32 The prevalence of exposure of the three ethnic groups in New Mexico to oestrogen replacement therapy is not known. Obesity, and thus, exposure to high levels of endogenous oestrogen, is more prevalent in Hispanic and American Indian women compared to non-Hispanic whites in New Mexico 33 but this observation contrasts with the lower incidence rates in these ethnic groups. More moderate risk factors for uterine cancer include nulliparity, 3, 31 advancing age, 34 high socioeconomic status, 35 and dietary factors including high fat 36 and low antioxidant intake. 37 Higher birth rates in American Indians and Hispanics compared with non-Hispanic whites in New Mexico over most of the last quartercentury 38 and declines in birth rates among Hispanics and American Indians over the span of the study, 38 are consistent with our data for the three ethnic groups (Table 1) . Socioeconomic status (as measured by the poverty rate) is lowest among non-Hispanic white (15%) and highest among American Indian women (46%). This is consistent with the relative ranking of incidence rates of uterine corpus cancer and probably reflects ethnic differences in parity (and possibly in access to oestrogen replacement therapy). Dietary studies among New Mexico's women, however, have shown comparably high fat intake among all three ethnic groups, and consumption of foods containing antioxidants among each ethnic group appears to meet recommended standards (Kathleen Koehler, personal communication). Diabetes 3,31 and hypertension 3, 31 are medical risk factors for uterine cancer. Diabetes is more prevalent in Hispanic and American Indian women in New Mexico 33 but contrasts with the lower incidence rates of uterine cancer in these two groups. The prevalence of hypertension in the three ethnic groups is similar (14%). 33 Poorer survival was found among older Hispanic and American Indian women compared to older nonHispanic white women. Hispanic and American Indian women may have less access to health care and thus, experience a delay in diagnosis and treatment of their medical problems. Older Hispanic and American Indian women may have been less likely than younger women in these groups, and less likely than non-Hispanic white women, to use postmenopausal hormone replacement therapy and have more aggressive tumours with resulting poorer survival.
Although case ascertainment and surveillance procedures have been consistent throughout the study period, ethnic differences in access to health care (and thus, to diagnoses) in New Mexico may exist. Ethnic misclassification is not problematic in our incidence or mortality data. 8, 12 Misclassification of cause of death related to uterine cancer was probably greater in the earlier years of the study, when cervical cancer deaths were more likely to have been included in the category of 'uterus, NOS' cancer deaths. 39 The small number of cases for American Indians results in mortality rates that were unstable over the time periods that we included in our analysis. The frequency of hysterectomy by ethnic group and time period in New Mexico also is not known, but data from the Behavioral Risk Factor Surveillance System for New Mexico 33 for 1993 indicate that comparable proportions of non-Hispanic whites and Hispanics had hysterectomies (approximately 40% for women Ͼ50 years of age), while for American Indians, 35% reported hysterectomies (although the numbers were small for American Indians). Hysterectomy rates are important to assess because hysterectomy removes the organ at risk for cancer and affects the denominator in rate calculations.
Despite these potential limitations, our data suggest strong ethnic differences in age-adjusted uterine cancer incidence rates in New Mexico. These differences in uterine cancer occurrence warrant further evaluation with appropriately-designed aetiologic studies.
